// App-Quantinova.ai

TP314 2016 ASA : Current Use of Strategies to Improve Door-to-Needle Times With Tissue Plasminogen Activator in Acute Ischemic Stroke: Findings From the Target: Stroke Phase II Survey

Researchers

Presenter

  • Barbara Lytle

Principal Investigators

  • Jason Blevins

  • Edward C Jauch

  • Lee H Schwamm

  • Gregg C Fonarow

  • Adrian F Hernandez

  • Eric D Peterson

  • Eric E Smith

  • Jeffrey L Saver

  • Steven R Messe

  • Mary Paulsen

  • Robert Suter

  • Mathew J Reeves

Medical Centers

  • Univ of Calgary, Calgary, Canada

  • Massachusetts General Hospital, Boston, MA

  • American Heart Association, El Paso, TX

  • University of California, Los Angeles, Los Angeles, CA

  • Medcl Univ of South Carolina, Charleston, SC

  • Michigan State University, Lansing, MI

  • Duke Hosp, Durham, NC

  • University of Pennsylvania, Philadelphia, PA

Locations

  • United States

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Genetic Disorder

  • Central Nervous System (CNS)

Disease

  • Ischemic stroke

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved